In brief, our study demonstrates that CD133 expression correlates with the differentiation of CC and indicates that CD133 is a potential indicator for differentiation and prognosis of human CC, the mechanisms of which, however, need to be investigated in further study. Here, PROM1 is linked to cholangiocarcinoma.